Characteristic | N (%) |
---|---|
Patients included | 414 (100) |
All-cause mortality | |
30-days | 51 (12.3) |
90-days | 69 (16.7) |
Sex | |
Female | 195 (47.1) |
Male | 219 (52.9) |
Acquisition | |
Community-acquired | 323 (78.1) |
Healthcare-associated | 73 (17.6) |
Hospital-acquired | 18 (4.3) |
Age category | |
< 50 | 69 (16.7) |
50–69 | 131 (31.6) |
70–79 | 104 (25.1) |
≥ 80 | 110 (26.6) |
Comorbid conditions | |
Malignancy | 90 (21.7) |
Renal failure | 24 (5.8) |
Diabetes mellitus | 51 (12.3) |
Hypertension | 98 (23.7) |
Coronary heart disease | 84 (20.3) |
Heart failure | 40 (9.7) |
Chronic pulmonary disease | 96 (23.2) |
Cerebral ischemic disease | 40 (9.7) |
Charlson comorbidity index (CCI) | |
0 | 144 (34.8) |
1–2 | 190 (45.9) |
≥ 3 | 80 (19.3) |
Severity of sepsis | |
Sepsis without organ failure | 267 (64.5) |
Severe sepsis | 110 (26.6) |
Septic shock | 37 (8.9) |
Pitt bacteremia score | |
0 | 126 (30.4) |
1 | 131 (31.6) |
2 | 72 (17.4) |
≥ 3 | 85 (20.6) |
Focus of infection | N (%) |
Abdomen | 4 (1.0) |
Lower respiratory tract | 344 (83.0) |
Upper respiratory tract | 11 (2.7) |
Skin/soft tissue/abscess/myositis | 13 (3.1) |
Meningitis | 26 (6.3) |
Unknown | 16 (3.9) |
Time period | |
1993–2002 | 134 (32.4) |
2003–2011 | 280 (67.6) |
Management | |
Treatment in Intensive Care Unit(ICU) | 136 (32.9) |
Treatment with vasopressors | 40 (9.6) |
Ventilator treatment | 16 (3.9) |
Penicillin-sensitive Streptococcus pneumoniae | 397 (97.8)a |